BZ NOTE On Exelixis Spike Higher: Traders Likely Viewing Co.'s Renal Cancer Treatment Optimistically Following Comment on Bristol-Myers Q2 Earnings Conference Call It Will Receive Negative CHMP Opinion For OPDIVO, A Potential Renal Cancer Treatment
Benzinga Newsdesk